FDA to attach rare nervous syndrome warning to Johnson & Johnson vaccine
[ad_1] The Food and Drug Administration plans to warn that Johnson & Johnson’s coronavirus vaccine may lead to an increased risk of a rare neurological disease known as Guillain-Barré syndrome, another setback for a vaccine that has been largely sidelined in the United States due to manufacturing problems and a temporary security hiatus earlier this … Read more